| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -9.2e-05 | 1 |